Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
International Journal of Cancer
|
April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg
Stefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
Cancer Immunity
|
February 8, 2013
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy
Anurag Gupta, Natko Nuber, Christoph Esslinger, et al.
Frontiers in Immunology
|
June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Mona O Mohsen, Monique Vogel, Carsten Riether, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2007
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy
Jean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2009
Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones, Andreas Wadle, Anja Hombach, et al.
International Journal of Cancer
|
November 29, 2007
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts
Jean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.
Cancer Immunity
|
July 17, 2003
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Jonathan Cebon, Elke Jäger, Mark J Shackleton, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 1, 2007
NY-BR-1 is a differentiation antigen of the mammary gland
Dirk Jäger, Valeriy Filonenko, Ivan Gout, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients
Senta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
International Journal of Cancer
|
April 23, 2009
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg
Stefan Bauer, Jeannette C Oosterwijk-Wakka, Nicole Adrian, et al.
Cancer Immunity
|
February 8, 2013
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy
Anurag Gupta, Natko Nuber, Christoph Esslinger, et al.
Frontiers in Immunology
|
June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Mona O Mohsen, Monique Vogel, Carsten Riether, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2007
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy
Jean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 25, 2009
Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones, Andreas Wadle, Anja Hombach, et al.
International Journal of Cancer
|
November 29, 2007
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts
Jean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.
Cancer Immunity
|
July 17, 2003
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
Jonathan Cebon, Elke Jäger, Mark J Shackleton, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
June 1, 2007
NY-BR-1 is a differentiation antigen of the mammary gland
Dirk Jäger, Valeriy Filonenko, Ivan Gout, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients
Senta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, et al.
Page
of 13